Frequencies and rates of genotypes of TLR4 polymorphisms in type 1 and type 2 diabetic patients with nephropathy and neuropathy
. | Type 1 diabetes . | . | . | . | Type 2 diabetes . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Asp/Asp and Thr/Thr genotypes . | Asp/Gly and Thr/Ile genotypes . | P . | OR . | Asp/Asp and Thr/Thr genotypes . | Asp/Gly and Thr/Ile genotypes . | P . | OR . | ||||||
Nephropathy (%) | 51 (23.2%) | 5 (19.2%) | 0.81 | 0.79 (0.28–2.20) | 183 (39.4%) | 23 (35.4%) | 0.59 | 0.84 (0.49–1.45) | ||||||
Neuropathy (%) | 64 (29.1%) | 7 (26.9%) | 1.00 | 0.90 (0.36–2.24) | 236 (50.9%) | 17 (26.2%) | 0.0002 | 0.34 (0.19–0.61) |
. | Type 1 diabetes . | . | . | . | Type 2 diabetes . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Asp/Asp and Thr/Thr genotypes . | Asp/Gly and Thr/Ile genotypes . | P . | OR . | Asp/Asp and Thr/Thr genotypes . | Asp/Gly and Thr/Ile genotypes . | P . | OR . | ||||||
Nephropathy (%) | 51 (23.2%) | 5 (19.2%) | 0.81 | 0.79 (0.28–2.20) | 183 (39.4%) | 23 (35.4%) | 0.59 | 0.84 (0.49–1.45) | ||||||
Neuropathy (%) | 64 (29.1%) | 7 (26.9%) | 1.00 | 0.90 (0.36–2.24) | 236 (50.9%) | 17 (26.2%) | 0.0002 | 0.34 (0.19–0.61) |
Data are means (asymptotic 95% CI) unless otherwise noted. P calculated with Fisher’s exact test.